Latest Breaking News On - Track capital - Page 1 : comparemela.com

Traders, Media Seek FOIA Docs about India Pharma

Traders, Media Seek FOIA Docs about India Pharma
lawstreetmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lawstreetmedia.com Daily Mail and Mail on Sunday newspapers.

United statesWhite houseDistrict of columbiaGeorgetown universityBruxelles capitaleLibrela bedinvetmabLonza biologicsMary denigan macauleyHogan lovellsParawada mandalCathy mcmorris rodgersr washSun pharma dadraZydus lifescienceSkyclarys omaveloxoloneSarah mcmullenEugia steriles

Novartis to Acquire Mariana for Up to $1 75B, Expanding Radiopharma Pipeline

Novartis to Acquire Mariana for Up to $1 75B, Expanding Radiopharma Pipeline
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Eli lillyMariana rltsFiona marshallAndrew tsaiAtlas ventureMariana oncologyBig pharmaAccess biotechnologyLast septemberTrack capitalNextech investSurveyor capitalPoint biopharma globalGood manufacturingShiva malek

SpringWorks Therapeutics, Inc (NASDAQ:SWTX) Insider Sells $751,500 00 in Stock

SpringWorks Therapeutics, Inc (NASDAQ:SWTX) Insider Sells $751,500 00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Daniel pichlVanguard group incBlackrock incSpringworks therapeutics company profileSpringworks therapeutics incGoldman sachs groupPricet rowe associates incSpringworks therapeuticsGet free reportStreet corpTrack capitalPricet rowe associatesWorks therapeuticsSpringworks therapeutics daily

Jason P Rhodes Sells 177,906 Shares of Dyne Therapeutics, Inc (NASDAQ:DYN) Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) Director Jason P. Rhodes sold 177,906 shares of the company’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $23.89, for a total transaction of $4,250,174.34. Following the completion of the transaction, the director now owns 7,148,211 shares in […]

United statesJasonp rhodesRaymond jamesBlackrock incVr adviserDyne therapeutics incDyne therapeutics company profileGoldman sachs group incDyne therapeuticsGet free reportDirector jasonTherapeutics stock downTrack capitalGoldman sachs groupSachs groupDyne therapeutics daily

Travere Therapeutics, Inc (NASDAQ:TVTX) Given Consensus Rating of Moderate Buy by Analysts

Travere Therapeutics, Inc (NASDAQ:TVTX) Given Consensus Rating of Moderate Buy by Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Ericm dubePiper sandlerStifel nicolausVanguard group incSecurities exchange commissionTravere therapeutics company profileTravere therapeutics incTravere therapeuticsGet free reportExchange commissionStreet corpPartners managementTrack capitalCapital managementVanguard groupGet free